Optoscribe

Deal Type
Growth Capital

Initial Investment
September 2018

Sector
Industrials & Engineering

Fund
Growth Capital | VCTs

Status
Realised

In January 2022 Optoscribe was acquired by a US corporate buyer generating a 1.9x initial return for investors. The Maven VCTs supported the company's growth through several funding rounds, enabling it to strengthen strategic partnerships and move into volume production. 

Optoscribe produces pioneering 3D photonic integrated circuits. Its innovative and proprietary laser direct-write technology produces optical components at a wafer level, primarily for optical transceiver manufacturers supplying the rapidly growing data centre market.

The company’s solution enables a simple and precise means of getting light to and from the components within optical transceivers and other photonic integrated circuits. This facilitates transceiver manufacturers to adopt more automated, high volume assembly processes resulting in substantial reductions in overall costs.

Optoscribe

The sale provides our investors with a good return in just over three years. The business has developed some very exciting technology and has made significant progress during the period of our investment, which is reflected by the interest shown in the company by a number of trade buyers and ultimately its acquisition by a US corporate.

David Milroy, Partner at Maven

Meet the lead executive(s)

David Milroy
David Milroy

Partner

Alan Robertson
Alan Robertson

Partner

Subscribe for email updates

close